🇺🇸 FDA
Patent

US 10314810

Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

granted A61KA61K31/35A61K31/353

Quick answer

US patent 10314810 (Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics) held by Northwestern University expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/35, A61K31/353, A61K45/06, A61P